OTC Advertisements In France To Carry COVID Warnings
Executive Summary
French advertisements for OTC drugs that treat symptoms which could be associated with COVID-19 are set to carry new warning statements following a recommendation by the country's medicines regulator.
You may also be interested in...
NSAID Use By COVID Patients Not Associated With Adverse Outcomes Or Mortality – Danish Study
Study of almost 10,000 COVID-19 patients finds use of ibuprofen and other NSAIDs does not increase chance of being hospitalized, admitted to the intensive care unit, or dying.
COVID-19 Mentions Prohibited From Supplement Ads - UK Regulator
Dietary supplement ads should not make any explicit or implicit references to COVID-19, with immunity boosting claims also strictly off limits, says UK regulator the Advertising Standards Authority.
Timely Acquisition Keeps Germany's Dermapharm Growing
With its Branded Pharmaceuticals division negatively impacted by the end of the COVID-19 pandemic, the timely acquisition of supplements firm Arkopharma ensured Dermapharm recorded double-digit sales growth in 2023.